Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $5.67, $0.03 better than the analyst estimate of $5.64. Revenue for the quarter came in at $10.89 billion versus the consensus estimate of $10.73 billion.

Thermo Fisher is initiating a guidance range for full year 2024 with revenue of $42.1 billion to $43.3 billion and adjusted EPS of $20.95 to $22.00.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.